• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恰加斯心肌病的治疗。

Treatment of Chagas cardiomyopathy.

机构信息

Postgraduate Course of Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, 30130 100 Belo Horizonte, MG, Brazil ; Hospital das Clínicas, Universidade Federal de Minas Gerais, 30130 100 Belo Horizonte, MG, Brazil ; Fundação Hospitalar do Estado de Minas Gerais, 30150 260 Belo Horizonte, MG, Brazil.

Postgraduate Course of Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, 30130 100 Belo Horizonte, MG, Brazil ; Hospital das Clínicas, Universidade Federal de Minas Gerais, 30130 100 Belo Horizonte, MG, Brazil.

出版信息

Biomed Res Int. 2013;2013:849504. doi: 10.1155/2013/849504. Epub 2013 Nov 24.

DOI:10.1155/2013/849504
PMID:24350293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3857751/
Abstract

Chagas' disease (ChD), caused by the protozoa Trypanosoma cruzi (T. cruzi), was discovered and described by the Brazilian physician Carlos Chagas in 1909. After a century of original description, trypanosomiasis still brings much misery to humanity and is classified as a neglected tropical disease prevalent in underdeveloped countries, particularly in South America. It is an increasing worldwide problem due to the number of cases in endemic areas and the migration of infected subjects to more developed regions, mainly North America and Europe. Despite its importance, chronic chagas cardiomyopathy (CCC) pathophysiology is yet poorly understood, and independently of its social, clinical, and epidemiological importance, the therapeutic approach of CCC is still transposed from the knowledge acquired from other cardiomyopathies. Therefore, the objective of this review is to describe the treatment of Chagas cardiomyopathy with emphasis on its peculiarities.

摘要

恰加斯病(ChD)由原生动物克氏锥虫(T. cruzi)引起,于 1909 年由巴西医生卡洛斯·查加斯(Carlos Chagas)发现并描述。在经历了一个世纪的原始描述后,锥虫病仍然给人类带来了巨大的痛苦,并被归类为在欠发达国家流行的被忽视的热带病,特别是在南美洲。由于流行地区的病例数量以及受感染的患者向更发达地区(主要是北美和欧洲)的迁移,该病已成为一个日益严重的全球问题。尽管恰加斯病很重要,但慢性恰加斯心肌病(CCC)的病理生理学仍未得到很好的理解,并且无论其社会、临床和流行病学的重要性如何,CCC 的治疗方法仍然是从其他心肌病获得的知识转化而来。因此,本综述的目的是描述恰加斯心肌病的治疗方法,并重点介绍其特点。

相似文献

1
Treatment of Chagas cardiomyopathy.恰加斯心肌病的治疗。
Biomed Res Int. 2013;2013:849504. doi: 10.1155/2013/849504. Epub 2013 Nov 24.
2
Chagas' heart disease in Europe: an emergent disease?欧洲的恰加斯心脏病:一种新出现的疾病?
J Cardiovasc Med (Hagerstown). 2008 Dec;9(12):1263-7. doi: 10.2459/JCM.0b013e32830eb6fe.
3
Diagnosis and management of Chagas disease and cardiomyopathy.**诊断和治疗**:恰加斯病和心肌病。
Nat Rev Cardiol. 2012 Oct;9(10):576-89. doi: 10.1038/nrcardio.2012.109. Epub 2012 Jul 31.
4
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.慢性恰加斯心脏病:一种即将成为全球性健康问题的疾病:流行病学、病因病理学、治疗、发病机制和实验室医学。
Heart Fail Rev. 2012 Jan;17(1):45-64. doi: 10.1007/s10741-010-9211-5.
5
Chagas Disease: Chronic Chagas Cardiomyopathy.恰加斯病:慢性恰加斯心肌病。
Curr Probl Cardiol. 2021 Mar;46(3):100507. doi: 10.1016/j.cpcardiol.2019.100507. Epub 2019 Dec 1.
6
Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy.贝那唑嗪治疗剂量不足可减轻慢性恰加斯心肌病小鼠的免疫反应分子途径。
Front Cell Infect Microbiol. 2021 Jul 14;11:692655. doi: 10.3389/fcimb.2021.692655. eCollection 2021.
7
The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis.叙利亚仓鼠作为恰加斯病扩张型心肌病的模型:定量超声心动图和组织病理学分析。
Microbes Infect. 2003 Oct;5(12):1116-24. doi: 10.1016/j.micinf.2003.07.001.
8
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).克氏锥虫所致心脏病(恰加斯病)的研究视角
Prog Cardiovasc Dis. 2009 May-Jun;51(6):524-39. doi: 10.1016/j.pcad.2009.02.001.
9
In Chagas disease, transforming growth factor beta neutralization reduces infection and improves cardiac performance.在恰加斯病中,转化生长因子β中和可减少感染并改善心脏功能。
Front Cell Infect Microbiol. 2022 Nov 30;12:1017040. doi: 10.3389/fcimb.2022.1017040. eCollection 2022.
10
[The third and new face of Chagas disease].[恰加斯病的新的第三方面貌]
Bull Soc Pathol Exot. 2016 Aug;109(3):139-42. doi: 10.1007/s13149-016-0507-4. Epub 2016 Jul 4.

引用本文的文献

1
Advances in the Understanding and Treatment of Chronic Chagas Cardiomyopathy.慢性查加斯心肌病的认识与治疗进展
Cardiol Res. 2024 Oct;15(5):340-349. doi: 10.14740/cr1665. Epub 2024 Sep 16.
2
Unraveling the Missing Pieces: Exploring the Gaps in Understanding Chagas Cardiomyopathy.解开缺失的环节:探索恰加斯心肌病认识上的差距。
Cureus. 2024 Aug 15;16(8):e66955. doi: 10.7759/cureus.66955. eCollection 2024 Aug.
3
Cardiac involvement in Chagas disease and African trypanosomiasis.恰加斯病和非洲锥虫病的心脏受累。
Nat Rev Cardiol. 2024 Dec;21(12):865-879. doi: 10.1038/s41569-024-01057-3. Epub 2024 Jul 15.
4
The health-related quality of life in patients with Chagas disease: the state of the art.恰加斯病患者的健康相关生活质量:现状。
Rev Soc Bras Med Trop. 2022 Mar 14;55:e0657. doi: 10.1590/0037-8682-0657-2021. eCollection 2022.
5
Determinants of Functional Capacity in Patients with Chagas Disease.克氏锥虫病患者的功能能力决定因素。
Arq Bras Cardiol. 2021 Nov;117(5):934-941. doi: 10.36660/abc.20200462.
6
Exercise tests in Chagas cardiomyopathy: an overview of functional evaluation, prognostic significance, and current challenges.恰加斯心肌病的运动试验:功能评估、预后意义及当前挑战概述。
Rev Soc Bras Med Trop. 2020;53:e20200100. doi: 10.1590/0037-8682-0100-2020. Epub 2020 Jul 3.
7
Analysis of Iron Metabolism in Chronic Chagasic Cardiomyopathy.慢性恰加斯病性心肌病中铁代谢的分析
Arq Bras Cardiol. 2019 Feb;112(2):189-192. doi: 10.5935/abc.20190006.
8
Six-minute walk test and incremental shuttle walk test in the evaluation of functional capacity in Chagas heart disease.六分钟步行试验和递增往返步行试验在恰加斯心脏病功能能力评估中的应用
J Exerc Rehabil. 2018 Oct 31;14(5):844-850. doi: 10.12965/jer.1836326.163. eCollection 2018 Oct.
9
High fat diet aggravates cardiomyopathy in murine chronic Chagas disease.高脂饮食加重慢性恰加斯病小鼠的心肌病。
Microbes Infect. 2019 Jan-Feb;21(1):63-71. doi: 10.1016/j.micinf.2018.07.001. Epub 2018 Jul 31.
10
Echocardiographic pattern of acquired heart diseases in Nigeria.尼日利亚后天性心脏病的超声心动图表现
Niger Med J. 2015 Jul-Aug;56(4):253-7. doi: 10.4103/0300-1652.169699.

本文引用的文献

1
Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease.植入式心脏复律除颤器在恰加斯病患者中的疗效和安全性。
Europace. 2013 Jul;15(7):957-62. doi: 10.1093/europace/eut011. Epub 2013 Feb 1.
2
Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.扩张型心肌病和肺动脉高压的免疫吸附治疗
Atheroscler Suppl. 2013 Jan;14(1):203-11. doi: 10.1016/j.atherosclerosissup.2012.10.029.
3
Chronic Chagas disease: from basics to laboratory medicine.慢性恰加斯病:从基础到实验室医学。
Clin Chem Lab Med. 2013 Feb;51(2):271-94. doi: 10.1515/cclm-2012-0316.
4
Diagnosis and management of Chagas disease and cardiomyopathy.**诊断和治疗**:恰加斯病和心肌病。
Nat Rev Cardiol. 2012 Oct;9(10):576-89. doi: 10.1038/nrcardio.2012.109. Epub 2012 Jul 31.
5
Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment.适配体结合和中和β1-肾上腺素能受体自身抗体:基础及其在心肌病治疗中的未来展望。
Trends Cardiovasc Med. 2011 Aug;21(6):177-82. doi: 10.1016/j.tcm.2012.05.006.
6
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.植入式心脏复律除颤器用于恰加斯心脏病二级预防的长期随访。
Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.
7
Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial.细胞治疗克氏心脏病(多中心细胞治疗心脏病研究的克氏心脏病分支):一项多中心随机试验。
Circulation. 2012 May 22;125(20):2454-61. doi: 10.1161/CIRCULATIONAHA.111.067785. Epub 2012 Apr 20.
8
Chagas heart disease: report on recent developments.恰加斯心脏病:近期进展报告。
Cardiol Rev. 2012 Mar-Apr;20(2):53-65. doi: 10.1097/CRD.0b013e31823efde2.
9
Chronic phase of Chagas disease: why should it be treated? A comprehensive review.恰加斯病慢性期:为何应该进行治疗?全面综述。
Mem Inst Oswaldo Cruz. 2011 Sep;106(6):641-5. doi: 10.1590/s0074-02762011000600001.
10
[I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy].[《拉丁美洲恰加斯心肌病诊断与治疗指南》]
Arq Bras Cardiol. 2011;97(2 Suppl 3):1-48.